First Personal Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-92
Closed -$13K – 651
2019
Q2
$13K Hold
92
– – ﹤0.01% 463
2019
Q1
$13K Hold
92
– – ﹤0.01% 458
2018
Q4
$11K Hold
92
– – ﹤0.01% 457
2018
Q3
$15K Sell
92
-13
-12% -$2.24K ﹤0.01% 445
2018
Q2
$18K Sell
105
-26
-20% -$4.25K 0.01% 409
2018
Q1
$20K Buy
131
+64
+96% +$9.39K ﹤0.01% 631
2017
Q4
$9K Hold
67
– – ﹤0.01% 806
2017
Q3
$10K Hold
67
– – ﹤0.01% 706
2017
Q2
$10K Hold
67
– – ﹤0.01% 714
2017
Q1
$10K Hold
67
– – ﹤0.01% 707
2016
Q4
$7K Buy
+67
New +$7.46K ﹤0.01% 782
2016
Q3
– Sell
-7
Closed -$1K – 827
2016
Q2
$1K Buy
+7
New +$1.03K ﹤0.01% 791

Other funds holding JAZZ

First Personal Financial Services's JAZZ Position: Q3 2019 in Review

First Personal Financial Services sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 92 shares — an estimated $13K sold.

First Personal Financial Services first reported a position in JAZZ in Q2 2016 and held it in 12 quarters. The position peaked at $20K in Q1 2018. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • First Personal Financial Services reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • First Personal Financial Services sold 92 Jazz Pharmaceuticals shares in Q3 2019, an estimated $13K.
  • First Personal Financial Services first reported a position in Jazz Pharmaceuticals in Q2 2016 and held it in 12 quarters.
  • First Personal Financial Services's Jazz Pharmaceuticals position peaked at $20K in Q1 2018.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on First Personal Financial Services's 13F filing for Q3 2019, filed 15 Oct 2019.